enVVeno Medical (enVVeno Medical) Total Stockholders Equity : $42.37 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is enVVeno Medical Total Stockholders Equity?

enVVeno Medical's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $42.37 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. enVVeno Medical's Book Value per Share for the quarter that ended in Mar. 2024 was $N/A. The ratio of a company's debt over equity can be used to measure how leveraged this company is. enVVeno Medical's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.03.

enVVeno Medical Total Stockholders Equity Historical Data

The historical data trend for enVVeno Medical's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

enVVeno Medical Total Stockholders Equity Chart

enVVeno Medical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

0.99

7.10

54.40

38.73

46.20

enVVeno Medical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															34.13	28.81	24.92	46.20	42.37

enVVeno Medical (NAS:NVNOW) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

enVVeno Medical's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(42.369	-	0)	/	0
	=	N/A

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

enVVeno Medical's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.344	+	0.973)	/	42.369
	=	0.03

enVVeno Medical Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of enVVeno Medical's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

enVVeno Medical (enVVeno Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » enVVeno Medical Corp (NAS:NVNOW) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

NVNO:USA 5HJ:Germany

Address

70 Doppler, Irvine, CA, USA, 92618

Website

https://www.envveno.com

enVVeno Medical Corp is a medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its lead product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).